The transgenic mice reached a humane endpoint within 5–11 weeks of active surveillance after ending carcinogen exposure, while the survival difference among sexes did not reach statistical significance (Median survival: Female: 56 days; Male: 43 days).
← all excerpts
Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations.
1
—
—